Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled nitric oxide for acute chest syndrome in children with sickle cell disease
2008-004949-28Phase 2Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2009
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute chest syndrome (ACS) and sickle cell disease (SCD) comparing Inhaled nitric oxide with Placebo nitrogen gas (2 arms). Primary endpoint: Need for blood transfusion. Started Jun 2009; status: terminated.
02
Drugs
nitric oxide
03
Conditions
acute chest syndrome (ACS)sickle cell disease (SCD)
Beyond the preview
Go deeper on 2008-004949-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004949-28.